ABSTRACT
CRISPR-Cas biology and technologies have been largely shaped to-date by the characterization and use of single-effector nucleases. In contrast, multi-subunit effectors dominate natural systems, represent emerging technologies, and were recently associated with RNA-guided DNA transposition. This disconnect stems from the challenge of working with multiple protein subunits in vitro and in vivo. Here, we apply cell-free transcription-translation (TXTL) to radically accelerate the characterization of multi-subunit CRISPR effectors and transposons. Numerous DNA constructs can be combined in one TXTL reaction, yielding defined biomolecular readouts in hours. Using TXTL, we mined phylogenetically diverse I-E effectors, interrogated extensively self-targeting I-C and I-F systems, and elucidated targeting rules for I-B and I-F CRISPR transposons using only DNA-binding components. We further recapitulated DNA transposition in TXTL, which helped reveal a distinct branch of I-B CRISPR transposons. These capabilities will facilitate the study and exploitation of the broad yet underexplored diversity of CRISPR-Cas systems and transposons.
● PAM-DETECT for rapid determination of PAMs for Type I CRISPR-Cas systems in TXTL
● Mining of Type I orthologs and characterization of extensively self-targeting systems
● TXTL-based assessment of DNA target recognition and transposition by CRISPR transposons
● Identification of a distinct branch of Type I-B CRISPR transposons
Competing Interest Statement
C.L.B. is a co-founder and member of the Scientific Advisory Board member for Locus Biosciences and is a member of the Scientific Advisory Board for Benson Hill. The other authors declare no competing interests.